Muhammad A. Khattak
35 Stirling Highway
Crawley, WA 6009, Australia
Crawley, WA 6009, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA network open
Published: February 17, 2026
Prognostic Value of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Lactate Dehydrogenase Level in Melanoma Patients Treated with Immune Checkpoint Inhibitors.
Journal: Cancer investigation
Published: November 13, 2025
Vibostolimab coformulated with pembrolizumab versus pembrolizumab alone as adjuvant therapy for high-risk stage IIB-IV melanoma (KEYVIBE-010): a randomised, double-blind, phase 3 study.
Journal: The Lancet. Oncology
Published: June 30, 2025
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 05, 2025
Melanoma update: is a cure now in sight?
Journal: Internal medicine journal
Published: December 06, 2024
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Long-term follow-up, crossover, and rechallenge with pembrolizumab in the phase III KEYNOTE-716 study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 06, 2024
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 26, 2024
Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Insights from the Western Australian Context.
Journal: Diseases (Basel, Switzerland)
Published: July 30, 2024
Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 Trial.
Journal: Annals of surgical oncology
Published: July 18, 2024
Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer.
Journal: Internal medicine journal
Published: May 13, 2024
Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trial.
Journal: Nature medicine
Published: April 02, 2024
Last Updated: 09/26/2026